Yourgene Health Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: BQB1 insiders have sold more shares than they have bought in the past 3 months.


Ownership Breakdown

What is the ownership structure of BQB1?
Owner TypeNumber of SharesOwnership Percentage
Public Companies7,791,9370.243%
Employee Share Scheme8,076,5390.252%
Private Companies145,331,3034.53%
VC/PE Firms399,264,61112.4%
Institutions1,238,678,59338.6%
Individual Insiders1,410,930,88244%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 339.2%.


Top Shareholders

Top 25 shareholders own 83.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.5%
BGF Investment Management Ltd.
399,264,611€2.4m0%0.63%
9.89%
Chia-Han Chang
315,849,418€1.9m4.27%no data
5.92%
Alexander Milne
189,000,000€1.1m0%no data
5.32%
Steven Myers
170,000,000€1.0m-9.09%no data
4.7%
ODDO BHF Asset Management SAS
150,000,000€899.3k0%0.01%
4.41%
A J Bell Holdings Limited, Asset Management Arm
140,773,882€844.0k972%0.01%
4.18%
Method Investments & Advisory Limited, Asset Management Arm
133,333,333€799.4k0%59.53%
3.09%
Tatton Investment Management Limited
98,634,881€591.4k0%100.0%
3.09%
Hubwise Nominees Limited
98,562,138€590.9k0%no data
2.67%
Lyn Rees
85,371,235€511.9k0%no data
2.43%
Charles Roberts
77,542,594€464.9k0%no data
2.36%
HSBC Global Asset Management (UK) Limited
75,387,289€452.0k180%no data
2.3%
Donald Hamilton
73,326,927€439.6k0%no data
2.29%
Paul Miskin
73,287,000€439.4k0%no data
2.12%
Barclays Bank PLC, Securities Investments
67,828,335€406.7k0%no data
2.01%
HBOS Investment Fund Managers Limited
64,317,904€385.6k266%no data
1.88%
Nicholas Mustoe
60,009,278€359.8k0%no data
1.88%
Oliver Levy
59,999,199€359.7k0%no data
1.78%
Ainne Naylor
56,721,806€340.1k0%no data
1.78%
Intuitive Investments Group Plc
56,721,806€340.1k0%no data
1.78%
Robert Naylor
56,721,806€340.1k0%no data
1.61%
Martin Wickham
51,450,000€308.5k0%no data
1.3%
TFS Group Holding I LLC
41,356,165€248.0k0%no data
1.21%
Spreadex.com Limited, Asset Management Arm
38,765,935€232.4k-46.4%0.98%
1.16%
Trium Capital Managers Ltd
37,000,000€221.8k0%0.16%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/08 15:44
End of Day Share Price 2023/09/07 00:00
Earnings2022/09/30
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yourgene Health Plc is covered by 6 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCavendish
Mark BrewerCavendish
Martin HallHardman & Co.